575 filings
424B3
PRTG
Portage Biotech Inc
12 Apr 24
Prospectus supplement
5:22pm
6-K
PRTG
Portage Biotech Inc
12 Apr 24
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
5:21pm
424B3
PRTG
Portage Biotech Inc
8 Mar 24
Prospectus supplement
5:30pm
6-K
PRTG
Portage Biotech Inc
8 Mar 24
Current report (foreign)
5:04pm
424B3
PRTG
Portage Biotech Inc
6 Mar 24
Prospectus supplement
9:36pm
6-K
3jr1bp0 2ej32tp2jxf
6 Mar 24
Current report (foreign)
9:11pm
6-K
cj557z6s
28 Feb 24
Company focused on adenosine platform clinical development
6:42pm
424B3
13f5sj8 26
28 Feb 24
Prospectus supplement
5:19pm
6-K
sv22yqps4ewr5 hu
28 Feb 24
Current report (foreign)
5:17pm
424B3
2ir8tv
18 Jan 24
Prospectus supplement
5:41pm
6-K
vvu4uk7mi
18 Jan 24
Current report (foreign)
5:09pm
424B3
3bw fxxqb78d721x8
4 Jan 24
Prospectus supplement
5:49pm
6-K
ldemf hpwih0wfe81mq
4 Jan 24
Current report (foreign)
8:10am
S-8
9bptstc9ax6p4hs
1 Dec 23
Registration of securities for employees
4:05pm
424B3
6t5qq3agjde1 b35l
28 Nov 23
Prospectus supplement
4:03pm
6-K
2x7k40yko10lvgd0t
28 Nov 23
PORT 2 and 6 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting
4:02pm
6-K
o5ifu8g cmyns1
28 Nov 23
Current report (foreign)
4:01pm
424B3
o9lde969f94
14 Nov 23
Prospectus supplement
6:00am
6-K
xi9wms
13 Nov 23
Current report (foreign)
6:10am
EFFECT
z41pm zgt
8 Nov 23
Notice of effectiveness
12:15am